Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)

Published:2013-01-10 Issue:9 Volume:56 Page:1197-1205
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Whitley Richard J.,Boucher Charles A.,Lina Bruno,Nguyen-Van-Tam Jonathan S.,Osterhaus Albert,Schutten Martin,Monto Arnold S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/56/9/1197/17851459/cis1220.pdf

Reference16 articles.

1. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

2. Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

3. Aoki FY Boivin G Roberts N . Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther 2007;12:603-16.

4. Resistant influenza A viruses in children treated with oseltamivir: descriptive study

5. Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance;Science Advances;2024-07-26

2. A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children;Scientific Reports;2024-06-20

3. Genetic characteristics of H1N1 influenza virus outbreak in China in early 2023;Virologica Sinica;2024-06

4. Antiviral options and therapeutics against influenza: history, latest developments and future prospects;Frontiers in Cellular and Infection Microbiology;2023-11-29

5. Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy;Microorganisms;2023-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3